| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $95.39M | $141.45M | $105.96M | $80.02M | $32.87M |
| R&D | $26.59M | $69.64M | $89.42M | $68.03M | $24.81M |
| SG&A | $68.80M | $71.81M | $16.53M | $11.99M | $8.05M |
| Operating Income | -$95.39M | -$141.45M | -$105.96M | -$80.02M | -$32.87M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$90.97M | -$24.34M | -$97.22M | -$76.25M | -$32.38M |
| EPS (basic) | -1.8800 | -0.5300 | -2.3200 | -1.9000 | -0.8200 |
| EPS (diluted) | -1.8800 | -1.4600 | -2.3200 | -1.9000 | – |
| Shares (diluted) | $48.30M | $46.60M | $41.93M | $40.20M | – |